Experience with prophylactic cimetidine therapy in high risk patients
Baltás, B.; Nagy, A.; Baradnay, G.; Pepó, J.
Orvosi Hetilap 121(50): 3043-3047
1980
ISSN/ISBN: 0030-6002 PMID: 7012746 Document Number: 160378
Document emailed within 1 workday
Related Documents
Møller, M.; Haghfelt, T. 2000: Primary prophylactic treatment with implantable defibrillator in high risk patients Ugeskrift for Laeger 162(31): 4160-4161Freeman, G.M. 1982: The efficacy of prophylactic antibiotics in high-risk patients undergoing cesarean section Journal of the American Osteopathic Association 81(9): 610-615
Geng, S.; Feng, F.-z.; Xiang, Y.; Wan, X.-r.; Zhou, Y. 2011: Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole Zhonghua Fu Chan Ke Za Zhi 46(1): 24-27
Borges, A.C.; Waldenberger, F.R.; Wolf, C.; Reindl, I.; Habedank, D.; Haisjackl, M.; Kox, W.J.; Konertz, W.; Baumann, G.; Kleber, F.X. 1996: Percutaneous "high risk" angioplasty with prophylactic cardiopulmonary support. High risk PTCA with mechanical circulatory support Zeitschrift für Kardiologie 85(Suppl 4): 21-28
Rajdev, S.; Krishnan, P.; Irani, A.; Kim, M.C.; Moreno, P.R.; Sharma, S.K.; Kini, A.S. 2008: Clinical application of prophylactic percutaneous left ventricular assist device (TandemHeart) in high-risk percutaneous coronary intervention using an arterial preclosure technique: single-center experience Journal of Invasive Cardiology 20(2): 67-72
Vijayasree, M. 2016: Efficacy of Prophylactic B-Lynch Suture during Lower Segment Caesarian Section in High Risk Patients for Atonic Postpartum Haemorrhage Kathmandu University Medical Journal 14(53): 9-12
Callea, A.; Piccinni, R.; Zizzi, V.; Sblendorio, D.; Berardi, B.; Tempesta, A.; Gala, F.G.; Traficante, A. 2010: High-intensity focused ultrasound (HIFU) in prostate cancer: a single centre experience in patients with low, intermediate or high-risk of progression Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 82(4): 253-255
Woods, J.E.; Anderson, C.F.; Johnson, W.J.; Donadio, J.V.; Frohnert, P.P.; Leary, F.J.; DeWeerd, J.H.; Taswell, H.F. 1973: Experience with renal transplantation in high risk patients Surgery Gynecology and Obstetrics 137(3): 393-398
Scatizzi, M.; Feroci, F.; Zironda, A.; Lenzi, E.; Baraghini, M.; Garzi, A.; Romoli, L.; Zalla, T.; Giudicissi, R.; Giani, I.; Elbetti, C.; Franceschin, M.; Cantafio, S. 2019: Enhanced recovery after surgery efficacy in an older patients and high-risk population affected by colorectal cancer: a more than 1000 patients experience Il Giornale di Chirurgia 40(6): 559-568
Bedard, M.P.; Shankaran, S.; Slovis, T.L.; Pantoja, A.; Dayal, B.; Poland, R.L. 1984: Effect of prophylactic phenobarbital on intraventricular hemorrhage in high-risk infants Pediatrics 73(4): 435-439
Nijssen, E.C.; Rennenberg, R.J.; Nelemans, P.J.; Essers, B.A.; Janssen, M.M.; Vermeeren, M.A.; van Ommen, V.; Wildberger, J.E. 2018: Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial Nederlands Tijdschrift Voor Geneeskunde 161: D1734
Lim, S.; Mora-Pinzon, M.; Park, T.; Yoon, W.; Crisostomo, P.R.; Cho, J.S. 2019: Medical therapy does not confer stroke prevention for all patients: identification of high-risk patients with asymptomatic carotid stenosis is still needed International Angiology: a Journal of the International Union of Angiology 38(5): 372-380
Krone, W.; Müller-Wieland, D. 1991: Drug therapy of high risk patients with diabetes mellitus Verhandlungen der Deutschen Gesellschaft für Innere Medizin 97: 238-242
Mattle, H.P. 2004: Clopidogrel as basic therapy in high-risk stroke patients Praxis 93(34): 1364
Neilan, L. 1976: Estrogen therapy intrahepatic cholestasis: Characteristics of high-risk patients Journal of the American Medical Women's Association 31(3): 97-104
Guthrie, R.M. 2015: The use of dual antiplatelet therapy in high-risk patients with acute coronary syndromes Journal of Family Practice 64(12 Suppl)
Cortesini, R.; Molajoni, E.R.; Berloco, P.; Bachetoni, A.; Cinti, P.; Trovati, A.; Sallusto, F.; Pretagostini, R.; Iapelli, M.; Caricato, M. 1989: Long-term follow-up of kidney grafts in high-risk patients under TLi and CsA therapy Transplantation Proceedings 21(1 Part 2): 1790-1792
Akhtar, M.; Avitall, B.; Jazayeri, M.; Tchou, P.; Troup, P.; Sra, J.; Axtell, K. 1992: Role of implantable cardioverter defibrillator therapy in the management of high-risk patients Circulation 85(1): I131-I139
Hermanides, R.S.; Ottervanger, J.P.; ten Berg, J.M.; Gosselink, A.T.M.; van Houwelingen, G.; Dambrink, J.-H.E.; Stella, P.R.; Hamm, C.; van 't Hof, A.W.J. 2012: Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score Journal of Invasive Cardiology 24(3): 84-89
Overgaard, M. 2000: Evaluation of radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy Rays 25(3): 325-330